6-51934368-T-C

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_138694.4(PKHD1):​c.5909-46A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.674 in 1,216,254 control chromosomes in the GnomAD database, including 281,706 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.70 ( 38157 hom., cov: 32)
Exomes 𝑓: 0.67 ( 243549 hom. )

Consequence

PKHD1
NM_138694.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5

Conservation

PhyloP100: 0.578

Publications

11 publications found
Variant links:
Genes affected
PKHD1 (HGNC:9016): (PKHD1 ciliary IPT domain containing fibrocystin/polyductin) The protein encoded by this gene is predicted to have a single transmembrane (TM)-spanning domain and multiple copies of an immunoglobulin-like plexin-transcription-factor domain. Alternative splicing results in two transcript variants encoding different isoforms. Other alternatively spliced transcripts have been described, but the full length sequences have not been determined. Several of these transcripts are predicted to encode truncated products which lack the TM and may be secreted. Mutations in this gene cause autosomal recessive polycystic kidney disease, also known as polycystic kidney and hepatic disease-1. [provided by RefSeq, Jul 2008]
PKHD1 Gene-Disease associations (from GenCC):
  • autosomal recessive polycystic kidney disease
    Inheritance: AR Classification: DEFINITIVE, SUPPORTIVE Submitted by: ClinGen, Myriad Women’s Health, Orphanet
  • polycystic kidney disease 4
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Labcorp Genetics (formerly Invitae), G2P, Laboratory for Molecular Medicine, Genomics England PanelApp
  • Caroli disease
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 6-51934368-T-C is Benign according to our data. Variant chr6-51934368-T-C is described in ClinVar as Benign. ClinVar VariationId is 262406.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.919 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_138694.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PKHD1
NM_138694.4
MANE Select
c.5909-46A>G
intron
N/ANP_619639.3
PKHD1
NM_170724.3
c.5909-46A>G
intron
N/ANP_733842.2

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
PKHD1
ENST00000371117.8
TSL:1 MANE Select
c.5909-46A>G
intron
N/AENSP00000360158.3
PKHD1
ENST00000340994.4
TSL:5
c.5909-46A>G
intron
N/AENSP00000341097.4

Frequencies

GnomAD3 genomes
AF:
0.703
AC:
106930
AN:
152002
Hom.:
38114
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.770
Gnomad AMI
AF:
0.467
Gnomad AMR
AF:
0.736
Gnomad ASJ
AF:
0.514
Gnomad EAS
AF:
0.941
Gnomad SAS
AF:
0.723
Gnomad FIN
AF:
0.741
Gnomad MID
AF:
0.557
Gnomad NFE
AF:
0.646
Gnomad OTH
AF:
0.640
GnomAD2 exomes
AF:
0.706
AC:
173908
AN:
246412
AF XY:
0.696
show subpopulations
Gnomad AFR exome
AF:
0.774
Gnomad AMR exome
AF:
0.811
Gnomad ASJ exome
AF:
0.518
Gnomad EAS exome
AF:
0.942
Gnomad FIN exome
AF:
0.735
Gnomad NFE exome
AF:
0.637
Gnomad OTH exome
AF:
0.646
GnomAD4 exome
AF:
0.670
AC:
713082
AN:
1064134
Hom.:
243549
Cov.:
14
AF XY:
0.669
AC XY:
366912
AN XY:
548196
show subpopulations
African (AFR)
AF:
0.764
AC:
19655
AN:
25738
American (AMR)
AF:
0.802
AC:
35323
AN:
44034
Ashkenazi Jewish (ASJ)
AF:
0.510
AC:
12066
AN:
23672
East Asian (EAS)
AF:
0.931
AC:
35232
AN:
37856
South Asian (SAS)
AF:
0.708
AC:
55367
AN:
78214
European-Finnish (FIN)
AF:
0.735
AC:
39023
AN:
53126
Middle Eastern (MID)
AF:
0.507
AC:
1701
AN:
3356
European-Non Finnish (NFE)
AF:
0.644
AC:
483682
AN:
750988
Other (OTH)
AF:
0.658
AC:
31033
AN:
47150
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
12762
25524
38286
51048
63810
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
10520
21040
31560
42080
52600
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.704
AC:
107029
AN:
152120
Hom.:
38157
Cov.:
32
AF XY:
0.711
AC XY:
52878
AN XY:
74366
show subpopulations
African (AFR)
AF:
0.770
AC:
31964
AN:
41504
American (AMR)
AF:
0.737
AC:
11272
AN:
15302
Ashkenazi Jewish (ASJ)
AF:
0.514
AC:
1784
AN:
3470
East Asian (EAS)
AF:
0.941
AC:
4849
AN:
5154
South Asian (SAS)
AF:
0.721
AC:
3473
AN:
4814
European-Finnish (FIN)
AF:
0.741
AC:
7846
AN:
10586
Middle Eastern (MID)
AF:
0.565
AC:
166
AN:
294
European-Non Finnish (NFE)
AF:
0.646
AC:
43899
AN:
67976
Other (OTH)
AF:
0.640
AC:
1351
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1604
3208
4812
6416
8020
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
822
1644
2466
3288
4110
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.659
Hom.:
128149
Bravo
AF:
0.705
Asia WGS
AF:
0.811
AC:
2821
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

Polycystic kidney disease 4 Benign:2
Sep 05, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Jun 19, 2021
Pars Genome Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

not specified Benign:1
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Autosomal recessive polycystic kidney disease Benign:1
Apr 12, 2018
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

not provided Benign:1
Jul 09, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
6.2
DANN
Benign
0.62
PhyloP100
0.58
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1266889; hg19: chr6-51799166; API